View of Efficacy and Safety of Lower- versus Higher-Dose Baxdrostat in Adults with Resistant or Uncontrolled Hypertension, Including a CKD-Enriched Population: An Indirect Subgroup Comparison from Placebo-Controlled Trials — A Systematic Review and Meta-Analysis with GRADE Assessment | ASIDE Endocrinology

← Efficacy and Safety of Lower- versus Higher-Dose Baxdrostat in Adults with Resistant or Uncontrolled Hypertension, Including a CKD-Enriched Population: An Indirect Subgroup Comparison from Placebo-Controlled Trials — A Systematic Review and Meta-Analysis with GRADE Assessment